A detailed history of Mayar Capital Ltd. transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, Mayar Capital Ltd. holds 19,672 shares of LH stock, worth $4.37 Million. This represents 3.95% of its overall portfolio holdings.

Number of Shares
19,672
Previous 20,119 2.22%
Holding current value
$4.37 Million
Previous $4.4 Million 8.92%
% of portfolio
3.95%
Previous 3.99%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$192.5 - $216.35 $86,047 - $96,708
-447 Reduced 2.22%
19,672 $4 Million
Q1 2024

May 03, 2024

SELL
$209.01 - $232.56 $632,673 - $703,959
-3,027 Reduced 13.08%
20,119 $4.4 Million
Q1 2023

Apr 25, 2023

SELL
$213.32 - $257.83 $2.66 Million - $3.22 Million
-12,480 Reduced 35.03%
23,146 $5.31 Million
Q4 2022

Jan 20, 2023

SELL
$203.72 - $248.97 $691,833 - $845,502
-3,396 Reduced 8.7%
35,626 $8.39 Million
Q3 2022

Oct 18, 2022

BUY
$204.81 - $262.19 $245,567 - $314,365
1,199 Added 3.17%
39,022 $7.99 Million
Q2 2022

Jul 26, 2022

BUY
$213.86 - $277.87 $1.32 Million - $1.72 Million
6,173 Added 19.5%
37,823 $8.86 Million
Q1 2022

Apr 21, 2022

BUY
$259.82 - $298.18 $237,995 - $273,132
916 Added 2.98%
31,650 $8.35 Million
Q4 2021

Jan 28, 2022

SELL
$271.6 - $314.21 $1.76 Million - $2.04 Million
-6,482 Reduced 17.42%
30,734 $9.66 Million
Q3 2021

Nov 02, 2021

SELL
$274.82 - $308.34 $1.94 Million - $2.18 Million
-7,075 Reduced 15.97%
37,216 $10.5 Million
Q2 2021

Jul 23, 2021

SELL
$251.87 - $278.14 $152,885 - $168,830
-607 Reduced 1.35%
44,291 $12.2 Million
Q1 2021

Apr 26, 2021

BUY
$204.88 - $255.03 $9.2 Million - $11.5 Million
44,898 New
44,898 $11.5 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $19.9B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Mayar Capital Ltd. Portfolio

Follow Mayar Capital Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mayar Capital Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mayar Capital Ltd. with notifications on news.